Moderna (MRNA) has a Smart Score of 2 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund Activity.
A high-level overview of Moderna, Inc. (MRNA) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
Moderna Inc. stock underperforms Friday when compared to competitors Nov. 15, 2024 at 4:32 p.m. ET by MarketWatch Automation Technology These Stocks Moved the Most Today: Applied Materials, Palantir, Tesla, Moderna, Super Micro, Alibaba, Bloom Energy, and More Nov. 15, 2024 at 4:11...
Price to Book Value 1.189 EV to EBITDA Upgrade Dividend Dividend -- Dividend Yield (Forward) Upgrade Financials Revenue (5 Year Growth) Upgrade Revenue (Quarterly YoY Growth) Upgrade EPS Diluted (5 Year Growth) Upgrade EPS Diluted (Quarterly YoY Growth) Upgrade Debt to Equity Ratio...
View Moderna (MRNA) stock price, news, historical charts, analyst ratings, financial information and quotes on Futubull. Trade commission-free with the Futubull stock trading app.
Price OscillatorDisparity IndexDonchian ChannelDonchian WidthEase of MovementEhler Fisher TransformElder Force IndexElder Impulse SystemElder Ray IndexFractal Chaos BandsFractal Chaos OscillatorGator OscillatorGopalakrishnan Range IndexHigh Low BandsHigh Minus LowHighest High ValueHistorical VolatilityIchimoku Clouds...
Moderna has seen a price pullback since our last update, but traders should keep waiting for a better buying opportunity. MRNA Trade Ideas May 28, 2024 6:52 PM EDT PROYou Know This Drill by Now There's good and bad news after Tuesday's all-too-familiar action. Let's review both cate...
Skip NavigationMarkets Business Investing Tech Politics Video Investing Club PRO Livestream
Novo Nordisk A/S 0.95% kr.3.32T AbbVie Inc. -0.44% $302.34B AstraZeneca PLC ADR -0.79% $197.68B AstraZeneca PLC 1.54% £154.88B Moderna Inc. -2.46% $16.73B Gilead Sciences Inc. -1.96% $117.46B Regeneron Pharmaceuticals Inc. -1.51% $90.22B Lonza Group AG -0.14% CHF40.26BAdvertisem...
Moderna’s share price was flat for a couple of years before exploding in 2020, up over 700% from the start of the year. Moderna operates in a crowded market. Moderna operates in a more isolated way than many big pharma competitors, and there are a number of other coronavirus vaccines ...